Rebapate tablets
Function and Efficacy
This product is a gastric mucosal protective agent. It can prevent the occurrence of ulcers and promote ulcer healing. It can increase gastric mucosal blood flow, the synthesis of prostaglandin E2 and gastric mucus secretion. It can remove oxygen free radicals, promote the healing of peptic ulcers and improve inflammation.
Ingredients
The main ingredient of this product is rebamipide.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| RebamipideIngredients |
This product is a gastric mucosal protective agent. It can prevent the occurrence of ulcers and promote ulcer healing. It can increase gastric mucosal blood flow, the synthesis of prostaglandin E2 and gastric mucus secretion. It can remove oxygen free radicals, promote the healing of peptic ulcers and improve inflammation. More |
90098-04-7 | 13 |
Appearance
This product is a film-coated tablet, which appears white after removing the coating.
Indication
Improvement of gastric mucosal lesions (erosion, bleeding, congestion, edema) in gastric ulcer, acute gastritis, and acute exacerbation of chronic gastritis.
Usage and Dosage
Gastric ulcer: Usually adults take 0.1g (1 tablet) at a time, 3 times a day, orally in the morning, evening and before bedtime. Improvement of acute gastritis and acute exacerbation of chronic gastritis gastric mucosal lesions (erosion, bleeding, congestion, edema): Usually adults take 0.1g (1 tablet) at a time, 3 times a day, orally.
Adverse Reactions
Abdominal distension, constipation, etc. According to reports, after taking rebamipide, thirst, dizziness, nausea, vomiting, heartburn, warm, abdominal pain, diarrhea, foreign body sensation in the throat, abnormal liver function, increased BuN, breast swelling, galactorrhea, irregular menstruation and allergic symptoms (itching, rash, eczema) may occur.
Precautions
It is contraindicated for those who are allergic to this product.
Special Population Medication
Precautions for children: The safety of this product for children has not been confirmed (little experience in use). Precautions for pregnancy and lactation: 1. Since the safety of administration during pregnancy has not been confirmed, pregnant women or women who may be pregnant can only be given the drug when it is judged that the benefits of treatment outweigh the risks. 2. According to animal experiment (rat) reports, the drug can be transferred into breast milk, so lactating women should avoid breastfeeding when taking the drug. Precautions for the elderly: Since the physiological functions of elderly patients are generally low, attention should be paid to the side effects of the digestive system.
Drug Interactions
No reports have been seen yet.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
0.1g (calculated as C19H15ClN2O4)
Validity Period
36 months
Manufacturer
ZheJiang Otsuka Pharmaceutical Co., Ltd.
-
Founded in:
1991-10-12 -
Address:
No. 1 Shangguafan, Jinnan Street, Lin'an District, Hangzhou City, Zhejiang Province -
Tax NO.:
91330100609129453D -
Registered Funds:
$54,333,333 -
Email: